Related Experiment Video
Updated: Jul 30, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae
K Weiss1, J de Azavedo, C Restieri
1Hôpital Maisonneuve-Rosemont, University of Montreal, 5415 L'Assomption, Montreal, Quebec H1T 2M4, Canada. weisscan@aol.com
Abstract:
New ketolides such as ABT-773 are a promising group of antibiotics in an era of increasing antibiotic resistance. We tested 704 invasive strains of Streptococcus pneumoniae collected from 1990 to 1998. Overall resistance was 8.3, 4.6, 4.5 and 3.6% for penicillin, cefuroxime, erythromycin and clarithromycin, respectively. By using a recommended breakpoint for susceptibility of <0.5 mg/L, no strains showed reduced susceptibility to ABT-773. ABT-773 was very active against all penicillin-resistant strains (MIC > 2 mg/L, with a mean geometric mean <0.06 mg/L), and against all 33 erythromycin-resistant strains, irrespective of the mode of resistance [mef- or erm(B)-mediated]. ABT-773 is a very active and promising agent against invasive strains of S. pneumoniae, including multiresistant strains.
Insights
New antibiotic ABT-773 shows strong activity against drug-resistant Streptococcus pneumoniae. This ketolide is effective against invasive strains, offering a promising option in the face of rising antibiotic resistance.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Antibiotic resistance is a growing global health concern.
- Streptococcus pneumoniae causes invasive infections and exhibits resistance to existing antibiotics.
- Ketolides represent a novel class of antibiotics with potential against resistant pathogens.
Purpose of the Study:
- To evaluate the in vitro activity of the new ketolide ABT-773.
- To assess the susceptibility of invasive Streptococcus pneumoniae strains to ABT-773.
- To determine the efficacy of ABT-773 against antibiotic-resistant strains of S. pneumoniae.
Main Methods:
- Testing of 704 invasive Streptococcus pneumoniae strains collected between 1990 and 1998.
- Determination of minimum inhibitory concentrations (MICs) for ABT-773.
- Evaluation of resistance mechanisms, including mef- and erm(B)-mediated resistance.
Main Results:
- No strains showed reduced susceptibility to ABT-773 at a breakpoint of <0.5 mg/L.
- ABT-773 demonstrated high activity against penicillin-resistant strains (MIC > 2 mg/L).
- The compound was highly effective against all 33 erythromycin-resistant strains, regardless of resistance mechanism.
Conclusions:
- ABT-773 is a highly active ketolide antibiotic.
- It shows significant promise for treating invasive infections caused by Streptococcus pneumoniae.
- ABT-773 is effective against multiresistant strains, addressing a critical need in infectious disease treatment.
More Related Videos
06:05Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance